Ferroptosis in health and disease
Carsten Berndt,Hamed Alborzinia,Vera Skafar Amen,Scott Ayton,Uladzimir Barayeu,Alexander Bartelt,Hülya Bayir,Christina M Bebber,Kivanc Birsoy,Jan P Böttcher,Simone Brabletz,Thomas Brabletz,Ashley R Brown,Bernhard Brüne,Giorgia Bulli,Alix Bruneau,Quan Chen,Gina M DeNicola,Tobias P Dick,Ayelén Distéfano,Scott J Dixon,Jan B Engler,Julia Esser-von Bieren,Maria Fedorova,José Pedro Friedmann Angeli,Manuel A Friese,Dominic C Fuhrmann,Ana J García-Sáez,Karolina Garbowicz,Magdalena Götz,Wei Gu,Linda Hammerich,Behrouz Hassannia,Xuejun Jiang,Aicha Jeridi,Yun Pyo Kang,Valerian E Kagan,David B Konrad,Stefan Kotschi,Peng Lei,Marlène Le Tertre,Sima Lev,Deguang Liang,Andreas Linkermann,Carolin Lohr,Svenja Lorenz,Tom Luedde,Axel Methner,Bernhard Michalke,Anna V Milton,Junxia Min,Eikan Mishima,Sebastian Müller,Hozumi Motohashi,Martina U Muckenthaler,Shohei Murakami,James A Olzmann,Gabriela Pagnussat,Zijan Pan,Thales Papagiannakopoulos,Lohans Pedrera Puentes,Derek A Pratt,Bettina Proneth,Lukas Ramsauer,Raphael Rodriguez,Yoshiro Saito,Felix Schmidt,Carina Schmitt,Almut Schulze,Annemarie Schwab,Anna Schwantes,Mariluz Soula,Benedikt Spitzlberger,Brent R Stockwell,Leonie Thewes,Oliver Thorn-Seshold,Shinya Toyokuni,Wulf Tonnus,Andreas Trumpp,Peter Vandenabeele,Tom Vanden Berghe,Vivek Venkataramani,Felix C E Vogel,Silvia von Karstedt,Fudi Wang,Frank Westermann,Chantal Wientjens,Christoph Wilhelm,Michele Wölk,Katherine Wu,Xin Yang,Fan Yu,Yilong Zou,Marcus Conrad
DOI: https://doi.org/10.1016/j.redox.2024.103211
Abstract:Ferroptosis is a pervasive non-apoptotic form of cell death highly relevant in various degenerative diseases and malignancies. The hallmark of ferroptosis is uncontrolled and overwhelming peroxidation of polyunsaturated fatty acids contained in membrane phospholipids, which eventually leads to rupture of the plasma membrane. Ferroptosis is unique in that it is essentially a spontaneous, uncatalyzed chemical process based on perturbed iron and redox homeostasis contributing to the cell death process, but that it is nonetheless modulated by many metabolic nodes that impinge on the cells' susceptibility to ferroptosis. Among the various nodes affecting ferroptosis sensitivity, several have emerged as promising candidates for pharmacological intervention, rendering ferroptosis-related proteins attractive targets for the treatment of numerous currently incurable diseases. Herein, the current members of a Germany-wide research consortium focusing on ferroptosis research, as well as key external experts in ferroptosis who have made seminal contributions to this rapidly growing and exciting field of research, have gathered to provide a comprehensive, state-of-the-art review on ferroptosis. Specific topics include: basic mechanisms, in vivo relevance, specialized methodologies, chemical and pharmacological tools, and the potential contribution of ferroptosis to disease etiopathology and progression. We hope that this article will not only provide established scientists and newcomers to the field with an overview of the multiple facets of ferroptosis, but also encourage additional efforts to characterize further molecular pathways modulating ferroptosis, with the ultimate goal to develop novel pharmacotherapies to tackle the various diseases associated with - or caused by - ferroptosis.